PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion.

Saved in:
Bibliographic Details
Title: PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion.
Authors: Guo Q; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Yaron JR; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Wallen JW 3rd; Exalt Therapeutics LLC, Las Vegas, NV, United States., Browder KF; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Boyd R; Center for Applied Structural Discovery, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Olson TL; Center for Applied Structural Discovery, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Burgin M; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Ulrich P; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Aliskevich E; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Schutz LN; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Fromme P; Center for Applied Structural Discovery, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Zhang L; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States., Lucas AR; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.
Source: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2021 Feb 16; Vol. 8, pp. 633212. Date of Electronic Publication: 2021 Feb 16 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33665212
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Guo+Q%22">Guo Q</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Yaron+JR%22">Yaron JR</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Wallen+JW+3rd%22">Wallen JW 3rd</searchLink>; Exalt Therapeutics LLC, Las Vegas, NV, United States.<br /><searchLink fieldCode="AU" term="%22Browder+KF%22">Browder KF</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Boyd+R%22">Boyd R</searchLink>; Center for Applied Structural Discovery, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Olson+TL%22">Olson TL</searchLink>; Center for Applied Structural Discovery, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Burgin+M%22">Burgin M</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Ulrich+P%22">Ulrich P</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Aliskevich+E%22">Aliskevich E</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Schutz+LN%22">Schutz LN</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Fromme+P%22">Fromme P</searchLink>; Center for Applied Structural Discovery, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Lucas+AR%22">Lucas AR</searchLink>; Center for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101653388%22">Frontiers in cardiovascular medicine</searchLink> [Front Cardiovasc Med] 2021 Feb 16; Vol. 8, pp. 633212. <i>Date of Electronic Publication: </i>2021 Feb 16 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101653388 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2297-055X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222297055X%22">2297055X </searchLink><i>NLM ISO Abbreviation: </i>Front Cardiovasc Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33665212
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fcvm.2021.633212
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 633212
    Titles:
      – TitleFull: PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guo Q
      – PersonEntity:
          Name:
            NameFull: Yaron JR
      – PersonEntity:
          Name:
            NameFull: Wallen JW 3rd
      – PersonEntity:
          Name:
            NameFull: Browder KF
      – PersonEntity:
          Name:
            NameFull: Boyd R
      – PersonEntity:
          Name:
            NameFull: Olson TL
      – PersonEntity:
          Name:
            NameFull: Burgin M
      – PersonEntity:
          Name:
            NameFull: Ulrich P
      – PersonEntity:
          Name:
            NameFull: Aliskevich E
      – PersonEntity:
          Name:
            NameFull: Schutz LN
      – PersonEntity:
          Name:
            NameFull: Fromme P
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Lucas AR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 02
              Text: 2021 Feb 16
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2297-055X
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: Frontiers in cardiovascular medicine
              Type: main
ResultId 1